http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2034568-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4ac611e5891fcf83c1d36f73f6ee7d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9777ff67e985cc3cf5a45c449feda918 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afaaa5ab719339d0998e01c6f8d9cd89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2128c1d1a8ee2970908b0062bb8d0221 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb695e44eb531a9deac4d1733f65f80f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5309d4a4fbc1f3b2d8bd0c34a6c6462 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25b2afc1df5222a4bbe08c2d88a4e1c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc32bce03a61bfb3f35656d6b255f6d9 |
| publicationDate | 1995-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2034568-C1 |
| titleOfInvention | Biologically active preparation for rabbits |
| abstract | FIELD: veterinary. SUBSTANCE: preparation has, wt.-%: proteins 3-50; amino acids 1.5-5; fatty acids 0.1-14; sugars 2.5-30; ascorbic acid 0.6-10; water 1-5, and mineral acid salts - the rest. Preparation is prepared by cultivation of virus- and/or nonvirus-induced lymphoid cells of rabbit following by filtration. Then one part of filtrate is lyophilized, dissolved in buffer solution and added (1:10) to aerosol OT solution, fatty acids (10-1000 mcg) and sugars (2-15 mg) were added and mixed with 1-5-fold acetone solution. Prepared precipitate is dissolved in saline solution, mixed with the second part of filtrate and lyophilized. Preparation with activity 10 000 U is administrated 2-3-fold by intranasal or parenteral route at the dose 0.5-1 ml for prophylaxis, and with activity 1 000 000 U is administrated 3-4-fold at the dose 1 ml two times per a day for treatment. EFFECT: enhanced effectiveness of preparation. 6 cl, 1 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2694626-C1 |
| priorityDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.